Notes
pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine
The study was funded by GlaxoSmithKline Biologicals SA.
Reference
Gomez JA, et al. Estimated Annual Health and Cost Impact of PHiD-CV Immunization Program in Brazil. Pediatric Infectious Disease Journal 38: e260-e265, No. 10, Oct 2019. Available from: URL: http://doi.org/10.1097/INF.0000000000002436
Rights and permissions
About this article
Cite this article
PCV immunisation in Brazil: large impact on pneumococcal disease. PharmacoEcon Outcomes News 839, 30 (2019). https://doi.org/10.1007/s40274-019-6311-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-6311-x